Healthcare provider profile · identity verified

Joseph C Behr, MD

Family Practice · MASON CITY, IA · NPI 1770699423

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	677	153
Losartan Potassium	Losartan Potassium	644	155
Metoprolol Succinate	Metoprolol Succinate	398	97
Pantoprazole Sodium	Pantoprazole Sodium	336	81
Amlodipine Besylate	Amlodipine Besylate	327	76
Levothyroxine Sodium	Levothyroxine Sodium	325	76
Rosuvastatin Calcium	Rosuvastatin Calcium	306	88
Gabapentin	Gabapentin	277	62
Lisinopril	Lisinopril	272	65
Tamsulosin Hcl	Tamsulosin Hcl	253	54
Simvastatin	Simvastatin	251	58
Omeprazole	Omeprazole	238	61
Furosemide	Furosemide	205	50
Allopurinol	Allopurinol	202	46
Carvedilol	Carvedilol	200	44
Fluoxetine Hcl	Fluoxetine Hcl	184	35
Warfarin Sodium	Warfarin Sodium	177	38
Metoprolol Tartrate	Metoprolol Tartrate	172	43
Tramadol Hcl	Tramadol Hcl	171	35
Buspirone Hcl	Buspirone Hcl	158	27
Hydrochlorothiazide	Hydrochlorothiazide	158	43
Metformin Hcl	Metformin Hcl	157	37
Trazodone Hcl	Trazodone Hcl	146	37
Clopidogrel	Clopidogrel Bisulfate	142	32
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	142	41
Duloxetine Hcl	Duloxetine Hcl	139	20
Ropinirole Hcl	Ropinirole Hcl	126	18
Eliquis	Apixaban	121	23
Famotidine	Famotidine	109	20
Spironolactone	Spironolactone	108	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	100	28
Sertraline Hcl	Sertraline Hcl	100	18
Albuterol Sulfate Hfa	Albuterol Sulfate	99	30
Montelukast Sodium	Montelukast Sodium	97	24
Bupropion Xl	Bupropion Hcl	90	16
Venlafaxine Hcl Er	Venlafaxine Hcl	85	17
Citalopram Hbr	Citalopram Hydrobromide	76	14
Alprazolam	Alprazolam	75	19
Trulicity	Dulaglutide	71	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	64	16
Ozempic	Semaglutide	61	14
Fluticasone Propionate	Fluticasone Propionate	54	16
Celecoxib	Celecoxib	52	14
Escitalopram Oxalate	Escitalopram Oxalate	46	12
Quetiapine Fumarate	Quetiapine Fumarate	46	suppressed
Metformin Hcl Er	Metformin Hcl	45	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Potassium Chloride	Potassium Chloride	43	11
Paroxetine Hcl	Paroxetine Hcl	42	suppressed
Atenolol	Atenolol	41	12
Torsemide	Torsemide	41	11
Irbesartan	Irbesartan	39	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	29
Triamcinolone Acetonide	Triamcinolone Acetonide	37	21
Meloxicam	Meloxicam	36	suppressed
Donepezil Hcl	Donepezil Hcl	35	suppressed
Nitroglycerin	Nitroglycerin	35	22
Jardiance	Empagliflozin	34	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	21
Ezetimibe	Ezetimibe	33	suppressed
Lovastatin	Lovastatin	33	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Finasteride	Finasteride	30	suppressed
Peg 3350-Electrolyte	Sodium Chloride/Nahco3/Kcl/Peg	30	29
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	28	suppressed
Ipratropium Bromide	Ipratropium Bromide	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Baclofen	Baclofen	27	13
Lorazepam	Lorazepam	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Aripiprazole	Aripiprazole	26	suppressed
Amoxicillin	Amoxicillin	25	17
Oxycontin	Oxycodone Hcl	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Xarelto	Rivaroxaban	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Loperamide	Loperamide Hcl	22	suppressed
Nystop	Nystatin	22	suppressed
Prednisone	Prednisone	22	17
Terbinafine Hcl	Terbinafine Hcl	19	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Nabumetone	Nabumetone	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Cephalexin	Cephalexin	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Amantadine	Amantadine Hcl	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Theophylline Er	Theophylline Anhydrous	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Jantoven	Warfarin Sodium	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Cefdinir	Cefdinir	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Pentoxifylline	Pentoxifylline	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Pulmicort Flexhaler	Budesonide	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error